BD (NYSE:BDX) announced today that it appointed Dr. Carrie Byington to its board of directors as the company’s 13th director.
Byington, an infectious disease expert, leads the nation’s largest academic health system as EVP and head of University of California Health (UCH).
Byington previously was dean of the College of Medicine and SVP of health sciences for Texas A&M University, as well as vice chancellor for health services across the Texas A&M 11-campus system. Before Texas A&M, Byington spent more than 20 years in teaching and leadership positions at the University of Utah.
Franklin Lakes, New Jersey-based BD said in a news release that Byington is the first Hispanic woman to have served in these health leadership roles in the U.S.
Byington has conducted extensive infectious disease research with a focus on respiratory pathogens, molecular diagnostics and pandemic preparedness. She was the chair of the Infectious Diseases Advisory Group for the U.S. Olympic Committee with responsibilities for protecting Team USA athletes and staff during the Zika Virus outbreak amid the 2016 Olympic Games in Brazil.
“Dr. Byington’s deep experience gained through her leadership positions at some of the nation’s largest health systems brings highly relevant and complementary integrated delivery network perspectives to BD and our board of directors,” BD Chair, CEO and President Tom Polen said in the release. “Dr. Byington is joining BD at one of the most exciting times in our company’s history, as we work to advance our BD 2025 strategy and accelerate innovation in smart connected care, enable the transition to new care settings and improve chronic disease outcomes.”